AGM/EGMJul 9, 2026, 06:02 AM
Aurora Cannabis Announces 2026 AGM; Reports Record FY26 Revenue $289M
AI Summary
Aurora Cannabis Inc. announced its 2026 Annual General Meeting (AGM) to be held virtually on August 7, 2026. The company reported a strong fiscal year 2026, achieving record annual global medical cannabis net revenue of $289 million, an 18% year-over-year increase, and record adjusted EBITDA of $54 million, up 32% year-over-year. International market revenue grew 29% to $177 million, and the company ended the year with $165 million in cash and no debt. Strategic developments included the acquisition of Safari Flower Company and the recognition of the US reclassification of medical cannabis.
Key Highlights
- Annual General Meeting scheduled for August 7, 2026, at 1:00 pm ET.
- Record annual global medical cannabis net revenue of $289 million, up 18% year-over-year.
- Record adjusted EBITDA of $54 million, growing 32% year-over-year.
- International market revenue reached $177 million, a 29% increase year-over-year.
- Ended fiscal year 2026 with a cash balance of $165 million and a debt-free business.
- Acquired Safari Flower Company to expand EU GMP capacity.
- Noted US reclassification of medical cannabis from Schedule I to Schedule III.
- Expanded patient access programs in Canada and Australia, and launched new products in Germany and Poland.
Price Impact
More from ACB